Lilly reports that retatrutide demonstrated high efficacy in clinical trials, achieving an astounding 28.7% weight loss in patients following weekly subcutaneous administration, compared with 15% for semaglutide (Ozempic/Wegovy) and 21% for tirzepatide
Diabetologia 46 , 10461062, doi:10.1007/s00125-003-1159-8 (2003)
Semaglutide is used to control blood sugar levels in people with type 2 diabetes to help with weight loss
Insurance and Payment Plans Hers does not accept insurance for compounded semaglutide
[DOI] [PubMed] [Google Scholar] 90.Rosenstock J, et al
Research confirms berberine reduces HbA1c, fasting glucose, post-meal glucose, and improves insulin sensitivity without causing low blood sugar, making it safe for long-term use